key: cord-0858710-6lfzth0c authors: Mishra, Ajay Kumar; Sahu, Kamal Kant; Lal, Amos; Sargent, Jennifer title: Patterns of heart Injury in COVID – 19 and relation to outcome date: 2020-04-08 journal: J Med Virol DOI: 10.1002/jmv.25847 sha: 263325c7c9b26dec61013e8b5ecfe31be340e82f doc_id: 858710 cord_uid: 6lfzth0c We read with much interest the article “Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China” by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK‐MB, Myoglobulin, cardiac troponin I (cTnI) and NT‐ proBNP on the outcome of 273 patients with COVID‐19 disease. This article is protected by copyright. All rights reserved. acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT-proBNP on the outcome of 273 patients with COVID-19 disease. Authors have suggested that elevated concentrations of these enzymes in venous blood were related to disease severity and poor outcome 1 . We believe that this topic is relevant and evolving. We have the following additional comments for further understanding of the disease and its various pathophysiological bases in cardiac involvement. Non ischemic and ischemic myocardial injury has been attributed to be the two principle Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation. 0(0) Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic Update on 3rd Coronavirus Outbreak of 21st Century COVID-19 and the cardiovascular system The Clinical Characteristics of Myocardial injury in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease